Skip to main content
Premium Trial:

Request an Annual Quote

Mark Straley, Jan Egberts

Agendia has appointed Mark Straley its CEO, succeeding Jan Egberts, who has served as the interim CEO since October 2014. 

Straley has more than 25 years of experience in developing and commercializing clinical diagnostics and laboratory services and most recently was president, anatomical pathology at Thermo Fisher Scientific. Prior to that, he was president and CEO of Metamark Genetics. Between 2005 and 2010, Straley was worldwide vice president of marketing, and then the worldwide president of Johnson & Johnson's Ortho Clinical Diagnostics.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.